192 related articles for article (PubMed ID: 34928263)
1. Comparison of p53, HSP90, E-cadherin and HPV in oral lichen planus and oral squamous cell carcinoma.
Bar JK; Cierpikowski P; Lis-Nawara A; Duc P; Hałoń A; Radwan-Oczko M
Acta Otorhinolaryngol Ital; 2021 Dec; 41(6):514-522. PubMed ID: 34928263
[TBL] [Abstract][Full Text] [Related]
2. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma].
Cao J; Jin JQ; Deng DJ; Liu HW
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914
[TBL] [Abstract][Full Text] [Related]
3. Caveolin-1 expression in oral lichen planus, dysplastic lesions and squamous cell carcinoma.
Jaafari-Ashkavandi Z; Aslani E
Pathol Res Pract; 2017 Jul; 213(7):809-814. PubMed ID: 28554768
[TBL] [Abstract][Full Text] [Related]
4. Salivary level of microRNA-146a and microRNA-155 biomarkers in patients with oral lichen planus versus oral squamous cell carcinoma.
Mehdipour M; Shahidi M; Anbari F; Mirzaei H; Jafari S; Kholghi A; Lotfi E; Manifar S; Mashhadiabbas F
BMC Oral Health; 2023 Jun; 23(1):433. PubMed ID: 37386382
[TBL] [Abstract][Full Text] [Related]
5. Oral lichen planus shows higher expressions of tumor suppressor gene products of p53 and p21 compared to oral mucositis. An immunohistochemical study.
Safadi RA; Al Jaber SZ; Hammad HM; Hamasha AA
Arch Oral Biol; 2010 Jun; 55(6):454-61. PubMed ID: 20427035
[TBL] [Abstract][Full Text] [Related]
6. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma.
Sun L; Feng J; Ma L; Liu W; Zhou Z
Ann Diagn Pathol; 2013 Dec; 17(6):486-9. PubMed ID: 23911820
[TBL] [Abstract][Full Text] [Related]
7. Comparison of biomarker expression in oral lichen planus and oral lichenoid lesions.
Radwan-Oczko M; Lis-Nawara A; Hałoń A; Bar J
Adv Clin Exp Med; 2022 Dec; 31(12):1327-1334. PubMed ID: 36047896
[TBL] [Abstract][Full Text] [Related]
8. Overestimated risk of transformation in oral lichen planus.
Cai X; Zhang J; Zhang H; Li T
Oral Oncol; 2022 Oct; 133():106025. PubMed ID: 35858493
[TBL] [Abstract][Full Text] [Related]
9. Cathepsin-B and caveolin-1 gene expressions in oral lichen planus and oral squamous cell carcinoma.
Pakfetrat A; Delavarian Z; Mohtasham N; Mohajer Tehran F; Samiee N
Mol Biol Rep; 2022 Apr; 49(4):2945-2951. PubMed ID: 35138525
[TBL] [Abstract][Full Text] [Related]
10. Aldehyde dehydrogenase 1 expression correlated with malignant potential of oral lichen planus.
Xu Z; Shen Z; Shi L; Sun H; Liu W; Zhou Z
Ann Diagn Pathol; 2013 Oct; 17(5):408-11. PubMed ID: 23707659
[TBL] [Abstract][Full Text] [Related]
11. Bmi1 expression in oral lichen planus and the risk of progression to oral squamous cell carcinoma.
Ma L; Wang H; Yao H; Zhu L; Liu W; Zhou Z
Ann Diagn Pathol; 2013 Aug; 17(4):327-30. PubMed ID: 23639414
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of proliferative potential in oral lichen planus and oral lichenoid lesions using immunohistochemical expression of p53 and Ki67.
Acay RR; Felizzola CR; de Araújo N; de Sousa SO
Oral Oncol; 2006 May; 42(5):475-80. PubMed ID: 16364678
[TBL] [Abstract][Full Text] [Related]
13. DNA content, Cyclooxygenase-2 expression and loss of E-cadherin expression do not predict risk of malignant transformation in oral lichen planus.
Neppelberg E; Johannessen AC
Eur Arch Otorhinolaryngol; 2007 Oct; 264(10):1223-30. PubMed ID: 17530268
[TBL] [Abstract][Full Text] [Related]
14. P53 and bcl-2 immunoexpression in patients with oral lichen planus and oral squamous cell carcinoma.
Leyva-Huerta ER; Ledesma-Montes C; Rojo-Botello RE; Vega-Memije E
Med Oral Patol Oral Cir Bucal; 2012 Sep; 17(5):e745-50. PubMed ID: 22549684
[TBL] [Abstract][Full Text] [Related]
15. Discrimination of oral squamous cell carcinoma from oral lichen planus by salivary metabolomics.
Ishikawa S; Sugimoto M; Edamatsu K; Sugano A; Kitabatake K; Iino M
Oral Dis; 2020 Jan; 26(1):35-42. PubMed ID: 31602722
[TBL] [Abstract][Full Text] [Related]
16. The genomic and proteomic landscape in oral lichen planus versus oral squamous cell carcinoma: a scoping review.
Xie F; Meves A; Lehman JS
Int J Dermatol; 2022 Oct; 61(10):1227-1236. PubMed ID: 35575880
[TBL] [Abstract][Full Text] [Related]
17. Metabolic changes during malignant transformation in primary cells of oral lichen planus: Succinate accumulation and tumour suppression.
Yang Q; Sun H; Wang X; Yu X; Zhang J; Guo B; Hexige S
J Cell Mol Med; 2020 Jan; 24(2):1179-1188. PubMed ID: 31793175
[TBL] [Abstract][Full Text] [Related]
18. Influence of topical corticosteroids on malignant transformation of oral lichen planus.
Bindakhil M; Akintoye S; Corby P; Stoopler ET; Greenberg MS; Shanti R; Tanaka TI; Sollecito TP
J Oral Pathol Med; 2022 Feb; 51(2):188-193. PubMed ID: 34748663
[TBL] [Abstract][Full Text] [Related]
19. Salivary KLK5 and uPA are potential biomarkers for malignant transformation of OLK and OLP.
Kang Y; Chen J; Li X; Luo M; Chen H; Cui B; Wang L; Lv D; Feng Y; Zhang P
Cancer Biomark; 2021; 31(4):317-328. PubMed ID: 33896830
[TBL] [Abstract][Full Text] [Related]
20. Expression of small leucine-rich extracellular matrix proteoglycans biglycan and lumican reveals oral lichen planus malignant potential.
Lončar-Brzak B; Klobučar M; Veliki-Dalić I; Sabol I; Kraljević Pavelić S; Krušlin B; Mravak-Stipetić M
Clin Oral Investig; 2018 Mar; 22(2):1071-1082. PubMed ID: 28779221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]